BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform

About this update from Bioadaptives, Inc.

BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform LAS VEGAS, NV / ACCESS Newswire / July 29, 2026 / BioAdaptives, Inc. (OTCID:BDPT), a developer of natural, science-backed wellness solutions, today announced a significant expansion of its digital storefront operations and direct-to-consumer (DTC) marketing footprint for its flagship cognitive performance line, MyndSystem™.The MyndSystem™ is a WADA-compliant, stimulant-free cognitive enhancement suite designed to support 24-hour brain performance. Following recent digital infrastructure updates at MyndSystem.com, the company has integrated a streamlined subscription model and optimized checkout flows, resulting in a marked increase in online visitor conversion rates and repeat customer acquisition."Consumers are increasingly seeking evidence-based, stimulant-free solutions to maintain mental acuity and focus." said James Keener, Chief Executive Officer of BioAdaptives®. "By streamlining our e-commerce operations, we are making it easier for high-performing professionals, athletes, and active seniors to access MyndSystem™ as a daily wellness ritual, thereby establishing a stable foundation of recurring DTC revenue."The MyndSystem™ comprises two complementary, research-backed formulations designed to target distinct phases of the circadian rhythm:MyndMed™ (Daytime Support): Formulated to support mental clarity, executive focus, and processing speed during active hours, with cholinergic and dopaminergic signaling support.MyndRenew™ (Bedtime Support): Formulated to support the brain's overnight restoration processes, including glymphatic clearance, neuroplasticity, and restorative sleep patterns.The MyndSystem (MyndMed and MyndRenew) is available at www.MyndSystem.com.In addition to scaling MyndSystem™, BioAdaptives remains on track with its commercial preparations for the upcoming launch of its Xcellara™ cellular wellness platform, scheduled for early August. The company expects these concurrent platforms to drive substantial brand awareness and revenue diversification through the remainder of 2026.About BioAdaptives, Inc.BioAdaptives® Inc. is the developer of the Xcellara™ line of stem cell mobilization and tissue-homing supplement...

View stock analysis, news, and events for Bioadaptives, Inc.